FDA’s window of “enforcement discretion” tied to the DSCSA product tracing requirements that went into effect at the beginning of the year will close on May 1, 2015. Are your systems in place?
This HDMA webinar, designed for manufacturers and other supply chain parties supporting DSCSA implementation activities, will provide an update on traceability implementation from a systems and technology perspective. Explore HDMA's ASN Exceptions Guidelines for the Drug Supply Chain Security Act and learn about data integration of DSCSA information. Additionally, hear from a panel of industry experts, who will share lessons learned from exchanging data and cover technical scenarios. Time for Q-and-A will be provided.
Speakers:
Atif Chaughtai, Director of Healthcare Solutions, Axway
Bruce Harold, Director of EDI, The Harvard Drug Group, LLC
John Miller, Senior Director, Industry Relations, HDMA